CME Stock Analysis: CME | NASDAQ
Financial Data & Stock Exchanges | NASDAQ, USA | Market Cap: 95.324m USD | 12M Return: 7% | US12572Q1058 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 458M
EPS Trend: 99.3%
Qual. Beats: 1
Rev. Trend: 98.4%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CME Group Inc. operates one of the worlds largest derivatives marketplaces, offering futures and options contracts across asset classes including interest rates, equity indexes, foreign exchange, and agricultural, energy, and metals commodities. Beyond trade execution, the company runs the central counterparty clearing function, guaranteeing and settling contracts and cleared swaps, which is a core revenue and risk-management pillar of the exchange business model. It also sells real-time and historical market data to a broad client base spanning professional traders, institutions, corporations, governments, and central banks. The company traces its origins to 1898 in Chicago and rebranded from Chicago Mercantile Exchange Holdings Inc. to CME Group Inc. in July 2007.
- Interest rate volatility drives Treasury futures trading volumes
- Geopolitical uncertainty boosts commodities and FX hedging demand
- Market data and analytics segment revenue expands steadily
| Net Income: 4.27b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.12 > 1.0 |
| NWC/Revenue: 42.02% < 20% (prev 41.21%; Δ 0.81% < -1%) |
| CFO/TA 0.02 > 3% & CFO 4.31b > Net Income 4.27b |
| Net Debt (1.15b) to EBITDA (5.37b): 0.21 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (362.2m) vs 12m ago 0.54% < -2% |
| Gross Margin: 81.89% > 18% (prev 86.53%; Δ -4.64% > 0.5%) |
| Asset Turnover: 3.62% > 50% (prev 3.58%; Δ 0.03% > 0%) |
| Interest Coverage Ratio: 29.74 > 6 (EBIT TTM 5.20b / Interest Expense TTM 174.9m) |
| A: 0.01 (Total Current Assets 162b - Total Current Liabilities 159b) / Total Assets 195b |
| B: 0.03 (Retained Earnings 5.46b / Total Assets 195b) |
| C: 0.03 (EBIT TTM 5.20b / Avg Total Assets 187b) |
| D: 0.16 (Book Value of Equity 26.5b / Total Liabilities 168b) |
| Altman-Z'' = 0.54 = B |
| DSRI: 1.07 (Receivables 753.1m/667.6m, Revenue 6.77b/6.44b) |
| GMI: 1.06 (GM 86.53% / 81.89%) |
| AQI: 0.89 (AQ_t 0.17 / AQ_t-1 0.19) |
| SGI: 1.05 (Revenue 6.77b / 6.44b) |
| TATA: -0.00 (NI 4.27b - CFO 4.31b) / TA 195b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of October 06, 2026, the stock is trading at USD 270.03 with a total of 1,547,055 shares traded. Over the past week, the price has changed by +2.58%, over one month by -2.49%, over three months by +15.56% and over the past year by +7.04%.
Current recommended Stop Loss: 254.80 (which is 5.6% or 2.6 ATR below the current price).
CME has received a consensus analysts rating of 3.53. Therefore, it is recommended to hold CME.
- StrongBuy: 4
- Buy: 5
- Hold: 5
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 283.6 | 5% |
P/E Trailing = 22.2213
P/E Forward = 21.9298
P/S = 14.1071
P/B = 3.6717
P/EG = 4.7092
Revenue TTM = 6.77b USD
EBIT TTM = 5.20b USD
EBITDA TTM = 5.37b USD
Long Term Debt = 3.42b USD (from longTermDebt, last quarter)
Short Term Debt = 55.8m USD (from shortTermDebt, last fiscal year)
Debt = 3.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.15b USD (calculated: Debt 3.42b - CCE 2.28b)
Enterprise Value = 96.5b USD (95.3b + Debt 3.42b - CCE 2.28b)
Interest Coverage Ratio = 29.74 (Ebit TTM 5.20b / Interest Expense TTM 174.9m)
EV/FCF = 22.90x (Enterprise Value 96.5b / FCF TTM 4.21b)
FCF Yield = 4.37% (FCF TTM 4.21b / Enterprise Value 96.5b)
FCF Margin = 62.20% (FCF TTM 4.21b / Revenue TTM 6.77b)
Net Margin = 63.08% (Net Income TTM 4.27b / Revenue TTM 6.77b)
Gross Margin = 81.89% ((Revenue TTM 6.77b - Cost of Revenue TTM 1.23b) / Revenue TTM)
Gross Margin QoQ = 69.25% (prev 88.14%)
Tobins Q-Ratio = 0.50 (Enterprise Value 96.5b / Total Assets 195b)
Interest Expense / Debt = 5.11% (Interest Expense 174.9m / Debt 3.42b)
Taxrate = 23.63% (1.32b / 5.59b)
NOPAT = 3.97b (EBIT 5.20b * (1 - 23.63%))
Current Ratio = 1.02 (Total Current Assets 162b / Total Current Liabilities 159b)
Debt / Equity = 0.13 (Debt 3.42b / totalStockholderEquity, last quarter 26.5b)
Debt / EBITDA = 0.21 (Net Debt 1.15b / EBITDA 5.37b)
Debt / FCF = 0.27 (Net Debt 1.15b / FCF TTM 4.21b)
Total Stockholder Equity = 27.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.28% (Net Income 4.27b / Total Assets 195b)
RoE = 15.53% (Net Income TTM 4.27b / Total Stockholder Equity 27.5b)
RoCE = 16.81% (EBIT 5.20b / Capital Employed (Equity 27.5b + L.T.Debt 3.42b))
RoIC = 11.16% (NOPAT 3.97b / Invested Capital 35.6b)
WACC = 5.17% (E(95.3b)/V(98.7b) * Re(5.22%) + D(3.42b)/V(98.7b) * Rd(5.11%) * (1-Tc(0.24)))
Discount Rate = 5.22% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 75.81 | Cagr: 0.30%
[DCF] Terminal Value 75.77% ; FCFF base≈4.17b ; Y1≈4.28b ; Y5≈4.73b
[DCF] Fair Price = 200.3 (EV 73.2b - Net Debt 1.15b = Equity 72.0b / Shares 359.6m; r=8.35% [WACC [floored]]; 5y FCF grow 2.56% → 2.50% )
EPS Correlation: 99.30 | EPS CAGR: 10.76% | SUE: 2.81 | # QB: 1
Revenue Correlation: 98.45 | Revenue CAGR: 8.86% | SUE: 1.34 | # QB: 1
EPS current Quarter (2026-09-30): EPS=2.94 | Chg30d=-0.15% | Revisions=-17% | Analysts=13
EPS current Year (2026-12-31): EPS=12.25 | Chg30d=-0.12% | Revisions=+0% | GrowthEPS=+9.4% | GrowthRev=+7.8%
EPS next Year (2027-12-31): EPS=12.93 | Chg30d=-0.03% | Revisions=+0% | GrowthEPS=+5.5% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: -7% (up=5, down=6)